ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNX Synectics Plc

333.00
-2.00 (-0.60%)
17 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synectics Plc LSE:SNX London Ordinary Share GB0007156838 ORD 20P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.60% 333.00 330.00 336.00 335.00 327.00 335.00 56,838 15:34:47
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Elec Apparatus & Equip-whsl 49.13M 2.16M 0.1281 26.00 56.58M
Synectics Plc is listed in the Elec Apparatus & Equip-whsl sector of the London Stock Exchange with ticker SNX. The last closing price for Synectics was 335p. Over the last year, Synectics shares have traded in a share price range of 137.50p to 365.00p.

Synectics currently has 16,889,000 shares in issue. The market capitalisation of Synectics is £56.58 million. Synectics has a price to earnings ratio (PE ratio) of 26.00.

Synectics Share Discussion Threads

Showing 101 to 122 of 900 messages
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
20/8/2007
09:04
Hi "Colin".

get yer bog brush ready.

cat
09/8/2007
20:11
Flush this into the vortex


Colin

smashingguy
31/7/2007
08:04
getting a bit smelly
CNP chicken came home to roost today
the stock market is not the place for a clinical research company - the market cannot cope with trial delays.

cat
10/7/2007
12:23
its a pile of plop
cat
04/5/2007
02:21
Yep, it would be great to see this sub 50p - providing the board are not telling porkies and the contracts are only overlapping end of year, then next results should be very strong.
papalpower
03/5/2007
15:49
One to watch-going down
volsung
24/2/2007
11:51
you are correct on that papalpower, but one has to say it must be truthful and it is slippage, but you will have to wait a long time to find out as it will not be this years results but the following year so do you want to tie an investment for a couple of years to find out, me i am out of here and will come back if there is no more profits warnings or further slippage, when in doubt get out, that is what i am doing, best of luck to those who stayed in and i hope you make a few bob, same to those who are getting in after my departure.
bigman
22/2/2007
11:16
Depends on how truthful the profit warning was.......is its correct and its purely slippage into next financial year, then on a forward basis next year will be better than original forecasts, at the expense of this year.
papalpower
22/2/2007
11:13
I dont think so re the bottom this came to market placed at 66p with no doubt a brokers forecast, issue a profit warning so they cannot possibly be worth more than 66p indeed one could say that a profit warning should half a share price ie in the 30p s simple logic what would they have been priced at on float with the current situation....i would suggest no where near 65p.... 35p more like.. IMHO
bigman
21/2/2007
13:57
Target: 26p.

Cheers
Lee

leytonorient
19/2/2007
15:11
And again.....

Worth a second look sub 50p.

2lb
15/2/2007
22:23
Down again today.
leytonorient
12/2/2007
23:05
Former Chief Operating Officer resigned in Feb I presume - why?
leytonorient
06/2/2007
12:41
cat:. Thanks for trying. Athough I have been associated with drug companies in the past the technology and theory hare is a bit byond me. Not too good an indicator that phone not answered.
pugugly
06/2/2007
10:48
pugugly - looks interesting but tried to ring the co to find out more and simply got an answering machine.
cat
06/2/2007
10:33
director buying today pathetic attempt to shore stock price up.
the company model is wrong and will likely fail.
big pharma want traditional full service CROs.
this co should never have come to market.
Institutional investors could have been stung and will be lucky to get any of their money back
pugugly i'll have a look.

cat
01/2/2007
22:00
never heard of this company till I read a feature article in today thursday's FT about Ian Smith.
after the fall seems worth a look

cerrito
01/2/2007
09:28
no bounce, just sinkinging still/
leytonorient
28/1/2007
10:55
Cash is prob
leytonorient
26/1/2007
19:15
Very unsettling news

The market doesn't like this. Unfortunately I feel we have significantly further to fall. It is particularly annoying after the recent encouraging results - shakes your confidence in the management. Hopeful of support at 50p

oharebj
26/1/2007
11:58
Cat:. Right as usual in your specialist area - Your post 17.

In this area do you have any knowledge of Epistem Ltd? - A private company that may be looking for funds. - If so what do you think of the technology - ?

Web site

Any thoughts would be appreciated.

pugugly
26/1/2007
11:11
I did look at the these but any business running a low cost model could always hit the buffers if the barriers to entry are also low.

Obviously not good to have a profits warning so soon after their December update, but with the market cap equal to their order book it makes it interesting to watch. Thats all I'll do for now though.

Not the most lively of BB's.

dr biotech
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock